Home / Market Reports / Pharma & Healthcare / Global Veterinary Drugs for Companion Animals Market Growth (Status and Outlook) 2022-2028

Global Veterinary Drugs for Companion Animals Market Growth (Status and Outlook) 2022-2028

Global Veterinary Drugs for Companion Animals Market Growth (Status and Outlook) 2022-2028

Product Code:408391

Published Date: Aug 04,2022

Pages: 103

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global market for Veterinary Drugs for Companion Animals is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Veterinary Drugs for Companion Animals market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Veterinary Drugs for Companion Animals market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Veterinary Drugs for Companion Animals market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Veterinary Drugs for Companion Animals market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Veterinary Drugs for Companion Animals players cover Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health and Bayer Animal Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Veterinary Drugs for Companion Animals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Veterinary Drugs for Companion Animals market, with both quantitative and qualitative data, to help readers understand how the Veterinary Drugs for Companion Animals market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Veterinary Drugs for Companion Animals market and forecasts the market size by Type (Injection and Taking Class,), by Application (Farm, Veterinary Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
    Injection
    Taking Class

Segmentation by application
    Farm
    Veterinary Clinic
    Others

Segmentation by region
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Major companies covered
    Zoetis
    Boehringer Ingelheim
    Merck Animal Health
    Elanco Animal Health
    Bayer Animal Health
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Meiji
    Ouro Fino Saude
    Parnell

Chapter Introduction
Chapter 1: Scope of Veterinary Drugs for Companion Animals, Research Methodology, etc.
Chapter 2: Executive Summary, global Veterinary Drugs for Companion Animals market size and CAGR, Veterinary Drugs for Companion Animals market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Veterinary Drugs for Companion Animals revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Veterinary Drugs for Companion Animals revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Veterinary Drugs for Companion Animals market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Virbac, Dechra Veterinary Products, Ceva and Vetoquinol, etc.
Chapter 14: Research Findings and Conclusion